Melphalan vs Mycophenolic
Mechanistic comparison of Melphalan and Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
18
Shared Targets
34%
Jaccard Similarity
28%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Melphalan and Mycophenolic share 18 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.340 means 34% of the combined target set is bound by both compounds. The IDF-weighted score of 0.284 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.